Skip to main content
BWAY
NASDAQ Industrial Applications And Services

BrainsWay's Accelerated Deep TMS Protocol Receives Draft Coverage from Highmark Blue Cross Blue Shield

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$22
Mkt Cap
$439.579M
52W Low
$7.84
52W High
$24.84
52W Position info
181% above low
Off High info
11% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BWAY has more than doubled off its 52-week low of $7.84.

Summary

BrainsWay announced that Highmark Blue Cross Blue Shield has issued a draft medical policy to cover its accelerated Deep TMS protocol for adolescent and adult major depressive disorder, significantly expanding market access for the recently FDA-cleared treatment.


Key Events · Product Development and Regulatory · BWAY

  • Draft Coverage Policy Issued

    Highmark Blue Cross Blue Shield released a draft medical policy to cover BrainsWay's accelerated Deep TMS™ protocol.

  • Expanded Patient Population

    The draft policy extends coverage to both adolescent and adult patients with major depressive disorder (MDD).

  • Accelerated Protocol Coverage

    The policy covers the SWIFT™ protocol, which offers a shorter, more flexible treatment course (38 sessions over 6 days acute + 4 weeks maintenance).

  • Significant Payer Impact

    Highmark covers over seven million lives, representing a substantial market opportunity for BrainsWay.


Analysis · BWAY · Industrial Applications And Services

This development is highly positive for BrainsWay as it signals broader reimbursement for its recently FDA-cleared accelerated Deep TMS protocol. Highmark Blue Cross Blue Shield covers over seven million lives, making this a substantial market access expansion. The accelerated protocol, requiring fewer clinic visits, could drive increased adoption and revenue growth for the company. While currently a draft, the anticipated February 2026 effective date suggests strong progress towards formal adoption.

How filings like this one have moved

In the 30 days to Nov 8, 2026, 46.9% of the 1569 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BWAY was trading at $22.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $439.6M. The 52-week trading range was $7.84 to $24.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BWAY - Latest Insights

BWAY
Sep 29, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $13.48
Real-time Price: $11.15 info
Change: -$2.33 (-17%) info
Market Cap: $449.681M info
BWAY
Aug 27, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $14.62
Real-time Price: $11.15 info
Change: -$3.47 (-24%) info
Market Cap: $449.681M info
BWAY
Aug 12, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.00
Real-time Price: $11.15 info
Change: -$3.85 (-26%) info
Market Cap: $449.681M info
BWAY
Jun 29, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $14.48
Real-time Price: $11.15 info
Change: -$3.33 (-23%) info
Market Cap: $449.681M info
BWAY
Jun 22, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $14.81
Real-time Price: $11.15 info
Change: -$3.66 (-25%) info
Market Cap: $449.681M info